The potential influence of plant polyphenols on the aging process

Forschende Komplementarmedizin

Volumn 17, Issue 4, 2010, Pages 181-187

  Cherniack, E Paul ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Lifespan; Plant; Polyphenol

Indexed keywords

CURCUMIN; FLAVONOID; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOL DERIVATIVE; PLANT EXTRACT; POLYPHENOLS; RESVERATROL; STILBENE DERIVATIVE; VASODILATOR AGENT;

AGING; CELL DIVISION; DRUG EFFECT; HUMAN; LIFE EXPECTANCY; LONGEVITY; PHYSIOLOGY; REVIEW;

AGING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CURCUMIN; FLAVONOIDS; HUMANS; LIFE EXPECTANCY; LONGEVITY; PHENOLS; PLANT EXTRACTS; STILBENES; VASODILATOR AGENTS;

EID: 77956571536     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000319143     Document Type: Conference Paper

References (86)

1. Blagosklonny MV: Aging and immortality: quasiprogrammed senescence and its pharmacologic inhibition. Cell Cycle 2006;5(18):2087-2102
2. Marques FZ, Markus MA, Morris BJ: The molecular basis of longevity, and clinical implications. Maturitas 2010;65(2):87-91.
3. Miura T, Mattson MP, Rao MS: Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 2004;3(6):333-343
4. Makino N, Maeda T, Oyama J, Higuchi Y, Mimori K: Improving insulin sensitivity via activation of PPAR-gamma increases telomerase activity in the heart of OLETF rats. Am J Physiol Heart Circ Physiol 2009;297(6):H2188-95.
5. Hornsby PJ: Telomerase and the aging process. Exp Gerontol 2007;42(7):575-581
6. Blagosklonny MV: Aging: ROS or TOR. Cell Cycle 2008;7(21):3344-3354
7. Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H: The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 2004;25(5):647-659
8. Beevers CS, Chen L, Liu L, Luo Y, Webster NJ, Huang S: Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res 2009;69 (3):1000-1008
9. Knutson MD, Leeuwenburgh C: Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr Rev 2008;66 (10):591-596
10. Kundu JK, Surh YJ: Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 2008;269(2):243-261
11. Ohio Agricultural Research and Development Center (OARDC), Ohio State University: Japanese knotweed. The Ohio perennial and biennial weed guide. www.oardc.ohio-state.edu/weedguide/ singlerecord.asp?id=230.
12. Gawne G: Resveratrol News. www.resveratrolnews. com/page50.htm.
13. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG et al: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425(6954):191-196
14. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M et al: Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004;430(7000):686-689
15. Valenzano DR, Cellerino A: Resveratrol and the pharmacology of aging: a new vertebrate model to validate an old molecule. Cell Cycle 2006;5(10): 1027-1032
16. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A: Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006;16 (3):296-300.
17. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A et al: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444(7117):337-342
18. Stefani M, Markus MA, Lin RC, Pinese M, Dawes IW, Morris BJ: The effect of resveratrol on a cell model of human aging. Ann N Y Acad Sci 2007; 1114:407-418
19. Shakibaei M, Harikumar KB, Aggarwal BB: Resveratrol addiction: to die or not to die. Mol Nutr Food Res 2009;53(1):115-128
20. Longo VD: Linking sirtuins, IGF-I signaling, and starvation. Exp Gerontol 2009;44(1-2):70-74
21. Donmez G, Guarente L: Aging and disease: connections to sirtuins. Aging Cell 2010;9:285-290
22. Trapp J, Jung M: The role of NAD+ dependent histone deacetylases (sirtuins) in ageing. Curr Drug Targets 2006;7(11):1553-1560
23. Blagosklonny MV: An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov Today 2007;12(5-6):218-224
24. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA et al: A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 2008; 3(6):e2264.
25. Baur JA: Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 2010;131(4): 261-269
26. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F et al: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006;127(6):1109-1122
27. Lopez-Lluch G, Irusta PM, Navas P, de Cabo R: Mitochondrial biogenesis and healthy aging. Exp Gerontol 2008;43(9):813-819
28. Rayalam S, Della-Fera MA, Baile CA: Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 2008;19(11):717-726
29. Fischer-Posovszky P, Unterkircher T, Fulda S, Debatin KM, Wabitsch M: Sirt1 Is Involved in Resveratrol-Stimulated Changes in Human Adipocytes. The Endocrine Society's Annual Meeting. San Francisco, CA, June 15-18, 2008.
30. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R et al: Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004;429(6993): 771-776
31. Szkudelska K, Nogowski L, Szkudelski T: Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J Steroid Biochem Mol Biol 2009;113(1-2):17-24.
32. Jing E, Gesta S, Kahn CR: SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/ deacetylation. Cell Metab 2007;6(2):105-114
33. Domnez G, Guarente L: Aging and disease: connections to sirtuins. Aging Cell 2010;9:285-290
34. Kanfi Y, Peshti V, Gil R, Naiman S, Nahum L, Kronfeld-Schor N, Cohen HY: SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 2010;9:162-173
35. Opie LH, Lecour S: The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 2007;28(14):1683-1693
36. Cacciapuoti F: Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: head and tail of same coin-resveratrol's role. Metab Syndr Relat Disord 2009;7(5):397-400.
37. Dandona P, Mohanty P, Ghanim H, Marumganti A, Sia C, Abuaysheh S, Rajeswari J: Resveratrol suppresses Pro-Inflammatory Genes Causing Insulin Resistance. The Endocrine Society's 90th Annual Meeting San Francisco, CA, 2008.
38. Zern TL, Wood RJ, Greene C, West KL, Liu Y, Aggarwal D et al: Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 2005;135(8):1911-1917
39. Vidavalur R, Otani H, Singal PK, Maulik N: Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 2006;11(3):217-225
40. Lekli I, Ray D, Das DK: Longevity nutrients resveratrol, wines and grapes. Genes Nutr 2010;5(55- 60).
41. Brown L, Kroon PA, Das DK, Das S, Tosaki A, Chan V et al: The biological responses to resveratrol and other polyphenols from alcoholic beverages. Alcohol Clin Exp Res 2009;33(9):1513-1523
42. Dudley JI, Lekli I, Mukherjee S, Das M, Bertelli AA, Das DK: Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol. J Agric Food Chem 2008;56(20):9362-9373
43. Pinzani P, Petruzzi E, Magnolfi SU, Malentacchi F, De Siena G, Petruzzi I et al: Red or white wine assumption and serum antioxidant capacity. Arch Gerontol Geriatr 2010 Jan 13 [Epub ahead of print].
44. Morre DJ, Morre DM, Shelton TB: Aging-related nicotinamide adenine dinucleotide oxidase response to dietary supplementation: the French paradox revisited. Rejuvenation Res 2010;13(2-3): 159-161
45. Calabrese V, Maines MD: Antiaging medicine: antioxidants and aging. Antioxid Redox Signal 2006;8(3-4):362-364
46. Calabrese V, Stella AM, Butterfield DA, Scapagnini G: Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid Redox Signal 2004;6(5):895-913.
47. Lu CC, Lai HC, Hsieh SC, Chen JK: Resveratrol ameliorates Serratia marcescens-induced acute pneumonia in rats. J Leukoc Biol 2008;83(4): 1028-1037
48. Zhou R, Fukui M, Choi HJ, Zhu BT: Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection. Br J Pharmacol 2009;158(2):462-474
49. Csaki C, Keshishzadeh N, Fischer K, Shakibaei M: Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol 2008;75(3):677-687
50. Pietsch K, Saul N, Menzel R, Sturzenbaum SR, Steinberg CE: Quercetin mediated lifespan extension in Caenorhabditis elegans is modulated by age-1, daf-2, sek-1 and unc-43. Biogerontology 2009;10(5):565-578
51. Saul N, Pietsch K, Menzel R, Steinberg CE: Quercetin-mediated longevity in Caenorhabditis elegans: Is DAF-16 involved? Mech Ageing Dev 2008;129(10):611-613
52. Yang JY, Della-Fera MA, Rayalam S, Ambati S, Hartzell DL, Park HJ et al: Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci 2008;82(19-20):1032-1039
53. Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM et al: Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1- dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008;29(9): 1807-1815
54. Psahoulia FH, Moumtzi S, Roberts ML, Sasazuki T, Shirasawa S, Pintzas A: Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells. Carcinogenesis 2007;28(5):1021-1031
55. Boots AW, Haenen GR, Bast A: Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008;585(2-3):325-337
56. Gorelik S, Ligumsky M, Kohen R, Kanner J: The stomach as a 'bioreactor': when red meat meets red wine. J Agric Food Chem 2008;56(13):5002-5007
57. Duthie GG, Gardner PT, Kyle JA: Plant polyphenols: are they the new magic bullet? Proc Nutr Soc 2003;62(3):599-603.
58. Bors W, Saran M: Radical scavenging by flavonoid antioxidants. Free Radic Res Commun 1987;2(4- 6):289-294
59. Singh A, Naidu PS, Kulkarni SK: Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid. Free Radic Res 2003;37(11):1245-1252
60. Boots AW, Li H, Schins RP, Duffin R, Heemskerk JW, Bast A et al: The quercetin paradox. Toxicol Appl Pharmacol 2007;222(1):89-96.
61. Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen GR: In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 2008;24(7-8):703-710
62. Zhang L, Chen W, Li X: A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells. FEBS Lett 2008;582(13):1821-1828
63. Wolter F, Clausnitzer A, Akoglu B, Stein J: Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J Nutr 2002;132(2):298-302.
64. de Sousa RR, Queiroz KC, Souza AC, Gurgueira SA, Augusto AC, Miranda MA et al: Phosphoprotein levels, MAPK activities and NFkappaB expression are affected by fisetin. J Enzyme Inhib Med Chem 2007;22(4):439-444
65. Yu S, Shen G, Khor TO, Kim JH, Kong AN: Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism. Mol Cancer Ther 2008;7(9):2609-2620
66. Itokawa H, Shi Q, Akiyama T, Morris-Natschke SL, Lee KH: Recent advances in the investigation of curcuminoids. Chin Med 2008;3:11.
67. Sa G, Das T: Anti cancer effects of curcumin: cycle of life and death. Cell Div 2008;3:14.
68. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N et al: Resveratrol delays agerelated deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008;8(2):157-168
69. Scalbert A, Williamson, G: Dietary intake and bioavailability of polyphenols. J Nutr 2000;130: 2073S-85S.
70. Bravo L: Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56(11):317-333
71. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB: Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4(6):807-818
72. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B et al: Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008;76(11):1590-1611
73. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL: Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 2010;54(1): 7-16.
74. Baur JA, Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5(6):493-506.
75. Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG: Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 2010;58(4):2095-2099
76. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL et al: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008;14(14):4491-4499
77. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A: Polymeric nanoparticle-encapsulated curcumin ('nanocurcumin'): a novel strategy for human cancer therapy. J Nanobiotechnology 2007;5:3.
78. Padhye S, Chavan D, Pandey S, Deshpande J, Swamy KV, Sarkar FH: Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. Mini Rev Med Chem 2010;10(5):372-387
79. Onoue S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmermann B et al: Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci 2010;99(4):1871-1881.
80. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR et al: Design of curcuminloaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010;79(3):330-338
81. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S: A pilot cross-over study to evaluate human oral bioavailability of bcm-95cg (biocurcumax). a novel bioenhanced preparation of curcumin. Indian J Pharm Sci 2008;70(4):445-449
82. Hu M: Commentary: bioavailability of flavonoids and polyphenols: call to arms. Mol Pharm 2007;4(6):803-806
83. Wesolowska O, Kuzdzal M, Strancar J, Michalak K: Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes. Biochim Biophys Acta 2009;1788 (9):1851-1860
84. Lila MA: From beans to berries and beyond: teamwork between plant chemicals for protection of optimal human health. Ann N Y Acad Sci 2007;1114:372-380
85. Wilson MA, Shukitt-Hale B, Kalt W, Ingram DK, Joseph JA, Wolkow CA: Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell 2006;5(1):59-68.
86. Seeram NP: Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J Agric Food Chem 2008;56(3):627-629